EssilorLuxottica
Tracked across 14 events · 376 articles · First seen Jun 16, 2025 · Last active Jun 05, 2026
Live sentiment trends, attention charts, and prominence tracking available on the
NewsDesk Dashboard
Business
Impact: EssilorLuxottica, as the parent company of EssilorLuxottica — Oakley and EssilorLuxottica — Ray-Ban, facilitates the collaboration between Meta Platforms and its eyewear brands, extending Meta Platforms' reach in the smart eyewear market.
Jun 16, 2025 · 8 articles
Business
Impact: EssilorLuxottica is a priority buyer for a 15% minority stake in the Adani Group, and Giorgio Armani also held a 2.5% stake in EssilorLuxottica, which will be distributed among his heirs.
Sep 12, 2025 · 7 articles
Tech
Impact: EssilorLuxottica, the parent company of EssilorLuxottica — Oakley and EssilorLuxottica — Ray-Ban, is continuing its multi-year partnership with Meta Platforms, leading to the launch of new smart glasses. This partnership strengthens EssilorLuxottica's position in the smart eyewear sector.
Jun 20, 2025 · 10 articles
Regulatory
Impact: EssilorLuxottica, maker of Ray-Ban, is one of the companies that have sued to safeguard potential tariff refunds.
Dec 01, 2025 · 7 articles
International
Impact: EssilorLuxottica is mentioned as one of the companies also pursuing IEEPA tariff refunds, indicating it could benefit from similar legal actions.
Feb 20, 2026 · 80 articles
Tech
Meta Platforms is preparing to test an AI-powered pendant within the next year, building on technology from its 2025 acquisition of Limitless. This initiative is part of a broader strategy to expand its AI-powered wearable…
Impact: EssilorLuxottica partners with Meta Platforms to manufacture AI-enabled smart glasses under the EssilorLuxottica — Ray-Ban and EssilorLuxottica — Oakley brands, contributing to Meta Platforms' broader wearable ecosystem.
May 30, 2026 · 8 articles
Business
Emerging Growth Research released a flash report on Diagnosis, a publicly traded Canadian corporation specializing in AI-powered early detection of eye-related health problems. The report highlights Diagnosis's progress towards key regulatory approvals with Canada —…
Impact: Diagnosis maintains commercial relationships with EssilorLuxottica>>>, which could accelerate the adoption of its CARA platform following regulatory approvals.
Jun 05, 2026 · 11 articles
NEWSDESK
Track EssilorLuxottica live
Set up alerts, explore relationships, view sentiment trends, and monitor how events impact this entity in real time.
Open Dashboard